During the fourth quarter ended December 2013 the healthcare firm reported a net profit of Rs 92.70 crore, up 107% compared with Rs 44.8 crore in the corresponding quarter last year.
Total income from operations during the quarter under review increased to Rs 488.30 crore up, 15% compared with Rs 422.80 crore in the fourth quarter ended December 2012.
Also Read
Further, the company's board at its meeting held on February 25, 2014, have proposed a final dividend of Rs 35 per equity share of face value Rs 10 each.
Sanofi India offers medicines for several therapeutic segments such as cardiology, thrombosis, oncology, central nervous system, diabetes, internal medicine and consumer healthcare.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%